Procedures

WWARN is continually updating a library of standardised procedures that offer guidance in the execution of various activities in the fields of clinical, in vitro, pharmacology, data collection and molecular analysis for antimalarial drug resistance researchers. Please read our tools and resources usage guidance.

For resources that relate to other infectious and emerging diseases, visit iddo.org.

Publication Code: QA09

A process for how training of trial staff will be planned and documented

Version: 2.0

Author(s): WWARN

Publication Code: IP02

Packaging and labeling investigational products/study drugs

Version: 2.0

Author(s): WWARN

Publication Code: SAF06

A process for the evacuation of a clinical trial facility in the event of a non-medical emergency

Version: v2.0

Author(s): WWARN

Publication Code: AD10

A process for preparing for and conducting participant follow-up visits during a clinical trial

Version: 2.0

Author(s): WWARN

Publication Code: AD11

A process for how clinical trial staff should record source and Case Record Form (CRF) data for trials

Version: 2.0

Author(s): WWARN

Publication Code: IP01

Central receipt of investigational product

Version: 2.0

Author(s): WWARN

Publication Code: AD06

A suggested process for how informed consent may be obtained from competent adults in a typical antimalarial clinical trial

Version: 2.0

Author(s): WWARN

Publication Code: AD09

The rationale and conduct of pre- and/or post-admission team meetings which help ensure the trial team works together correctly and efficiently

Version: 2.0

Author(s): WWARN

Publication Code: AD08

Clinical conduct of scheduled admission periods

Version: 2.0

Author(s): WWARN

Publication Code: AD05

A process for preparing for and conducting participant screening during a clinical trial

Version: 2.0

Author(s): WWARN